Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Targeting and modifying the stem cell niche can improve regenerative therapies.

Targeting macrophages may improve wound healing.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Targeting TRP channels may help reduce excessive scarring.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Targeting specific genes in certain pathways may help treat male pattern baldness.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Targeting CXCL12 may help treat hair loss caused by androgens.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Genetic differences affect COVID-19 severity and treatment development.

Adipokines affect skin health and could be targeted for treating skin diseases.